AF
RMD icon

Amalgamated Financial’s ResMed RMD Stock Holding History

Amalgamated Financial’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$9.93M Buy
+40,959
New +$9.91M 0.08% 209

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Amalgamated Financial's RMD Position: Q1 2022 in Review

Amalgamated Financial opened a new position in ResMed (RMD) in Q1 2022: 40,959 shares worth $9.93M. The stake represents 0.08% of the portfolio and ranks #209 among its holdings.

683 funds tracked by Wall St. Rank hold RMD as of Q1 2022.

  • Amalgamated Financial held 40,959 shares of ResMed worth $9.93M as of Q1 2022.
  • ResMed was a new Amalgamated Financial position in Q1 2022.
  • ResMed made up 0.08% of Amalgamated Financial's portfolio in Q1 2022, its #209 holding.
  • 683 funds tracked by Wall St. Rank held ResMed as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.